T细胞亚群的生物学特性及临床应用进展 |
| |
引用本文: | 刘超,徐志国,杨旭巍,盛小琦,薛飞,贡波,闫铭杰.T细胞亚群的生物学特性及临床应用进展[J].转化医学杂志,2014,3(6):377-380. |
| |
作者姓名: | 刘超 徐志国 杨旭巍 盛小琦 薛飞 贡波 闫铭杰 |
| |
作者单位: | 协和华东干细胞基因工程有限公司浙江省脐带血造血干细胞库;协和华东干细胞基因工程有限公司浙江省脐带血造血干细胞库;协和华东干细胞基因工程有限公司浙江省脐带血造血干细胞库;协和华东干细胞基因工程有限公司浙江省脐带血造血干细胞库;协和华东干细胞基因工程有限公司浙江省脐带血造血干细胞库;协和华东干细胞基因工程有限公司浙江省脐带血造血干细胞库;中国医学科学院血液学研究所 |
| |
摘 要: | 细胞免疫治疗技术作为一项新的治疗手段,近年来在临床上相对传统疗法发挥了其特有的优势,已逐渐成为研究的热点。T细胞作为免疫细胞的重要组成部分,已在细胞治疗领域得到越来越广泛的应用。作者对辅助型T细胞、细胞毒性T细胞和调节性T细胞3类亚群的作用机制与临床应用进行综合评述,并对树突状细胞 细胞因子诱导的杀伤细胞、自然杀伤T细胞、γδ T细胞、CD3单克隆抗体激活的杀伤细胞4种T细胞亚群在肿瘤治疗领域的应用进行详细比较。随着医学免疫学、细胞生物学及病理生理学的发展,细胞免疫治疗将发挥其更为重要的作用。
|
关 键 词: | T细胞 树突状细胞 细胞因子诱导的杀伤细胞 自然杀伤T细胞 γδ T细胞 CD3单克隆抗体激活的杀伤细胞 免疫治疗 |
Biological characteristics and clinical application of T cell subsets |
| |
Authors: | LIU Chao XU Zhiguo YANG Xuwei SHENG Xiaoqi XUE Fei GONG Bo and YAN Mingjie |
| |
Institution: | Zhejiang Province Umbilical Cord Blood Stem Cell Bank, Stem Cell Gene Engineering Co Ltd, Huzhou ,Zhejiang 313001,China;Zhejiang Province Umbilical Cord Blood Stem Cell Bank, Stem Cell Gene Engineering Co Ltd, Huzhou ,Zhejiang 313002,China;Zhejiang Province Umbilical Cord Blood Stem Cell Bank, Stem Cell Gene Engineering Co Ltd, Huzhou ,Zhejiang 313003,China;Zhejiang Province Umbilical Cord Blood Stem Cell Bank, Stem Cell Gene Engineering Co Ltd, Huzhou ,Zhejiang 313004,China;Zhejiang Province Umbilical Cord Blood Stem Cell Bank, Stem Cell Gene Engineering Co Ltd, Huzhou ,Zhejiang 313005,China;Zhejiang Province Umbilical Cord Blood Stem Cell Bank, Stem Cell Gene Engineering Co Ltd, Huzhou ,Zhejiang 313006,China;Institute of Hematology,Chinese Academy of Medical Scienees,Tianjin 300020,China |
| |
Abstract: | Cellular immune therapy as a new treatment, play its unique clinical advantages to traditional therapy in recent years. It has gradually become the research hot spot. T cells as an important part of the immune cells, have been widely used in the field of cell therapy. In this paper, we give a comprehensive review on the mechanism and clinical application of 3 classes of T cell subgroup, i.e. assistive T calls, cytotoxic T cells and regulatory T cells, and 4 types of commonly used cells in the field of tumor treatment, i.e. dendritic cells cytokine induced killer cells, natural killer T cells, gamma delta T and CD3AK cells. With the development of medical immunology, cell biology and pathophysiology, cellular immune therapy will play an important role. |
| |
Keywords: | T cells Dendritic cells cytokine induced killer cells (DC CIK) Natural killer T cells (NKT) Gamma delta T cells CD3 monoclonal antibody activated killer cells(CD3AK) Immunotherapy |
|
| 点击此处可从《转化医学杂志》浏览原始摘要信息 |
| 点击此处可从《转化医学杂志》下载免费的PDF全文 |
|